Kerecis will demonstrate its portfolio of intact fish‑skin grafts for reconstructive surgery at Plastic Surgery The Meeting 2025 and host a “Taste of Iceland” event featuring Dr Matthew Endara.

Kerecis, a company developing biologic materials derived from fish skin, will present its reconstructive‑surgery grafts at Plastic Surgery The Meeting (PSTM) 2025, taking place October 9–12 in New Orleans. The company will exhibit at booth 1819. Kerecis will display its line of intact fish‑skin grafts adapted for reconstructive use, including SurgiBind Tendon Protect, SurgiClose Silicone, SurgiClose Micro, and GraftGuide for burn wound management.

Fertram Sigurjonsson, founder and CEO, commented, “Plastic surgeons are on the front lines of restoring form and function, and our intact fish‑skin grafts offer a unique, clinically proven option to support their work.”

The company will also host a Taste of Iceland event during the meeting, featuring Icelandic culture and food, and a keynote by Dr Matthew Endara titled “Scaling the Reconstructive Ladder with Fish Skin: A New Paradigm in Soft Tissue Repair.”

Reconstructive Graft Portfolio

Kerecis’ graft offerings span multiple reconstructive needs: SurgiBind Tendon Protect is intended to protect newly repaired tendons and reduce scarring and adhesions; SurgiClose Silicone is paired with a non‑adhesive silicone layer for surgical wounds with exudate management; SurgiClose Micro is designed for filling deep, irregular wound geometries; and GraftGuide supports burn wound regeneration.

Event Strategy and Engagement

In addition to its exhibit presence, Kerecis aims to engage attendees through its hosted event, with the keynote intended to underscore how its grafts may extend reconstructive options for complex soft‑tissue cases.

About Kerecis

Kerecis produces fish‑skin and fatty acid–based biologics for tissue regeneration, using gently processed, sustainably sourced Icelandic fish skin that maintains structural and molecular properties. The company cites that there is no risk of disease transfer between cold‑water fish and humans, and claims that its materials allow faster wound healing compared to competitor products. Kerecis is part of Coloplast.

Photo: Kerecis